| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1838* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 615* | 2021 |
| Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community A Gupta, R Wood, R Kaplan, LG Bekker, SD Lawn PloS one 7 (3), e34156, 2012 | 285 | 2012 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 232 | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 218 | 2022 |
| Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study L Hunt, A Gupta-Wright, V Simms, F Tamba, V Knott, K Tamba, ... The Lancet infectious diseases 15 (11), 1292-1299, 2015 | 216 | 2015 |
| Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised … A Gupta-Wright, EL Corbett, JJ van Oosterhout, D Wilson, D Grint, ... The Lancet 392 (10144), 292-301, 2018 | 207 | 2018 |
| Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute … SD Lawn, AD Kerkhoff, R Burton, C Schutz, A Boulle, M Vogt, ... BMC medicine 15, 1-16, 2017 | 141 | 2017 |
| Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and … SD Lawn, A Gupta-Wright Transactions of the royal society of tropical medicine and hygiene 110 (3 …, 2016 | 117 | 2016 |
| Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan … A Gupta-Wright, JA Peters, C Flach, SD Lawn BMC medicine 14, 1-11, 2016 | 93 | 2016 |
| Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa A Gupta, R Wood, R Kaplan, LG Bekker, SD Lawn PloS one 8 (2), e55824, 2013 | 72 | 2013 |
| The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study AD Kerkhoff, R Wood, FG Cobelens, A Gupta-Wright, LG Bekker, ... BMC Medicine 13 (1), 70, 2015 | 67 | 2015 |
| Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study A Gupta-Wright, K Fielding, JJ van Oosterhout, M Alufandika, DJ Grint, ... The Lancet HIV 7 (9), e620-e628, 2020 | 65 | 2020 |
| Xpert MTB/RIF―why the lack of morbidity and mortality impact in intervention trials? AF Auld, KL Fielding, A Gupta-Wright, SD Lawn Transactions of the Royal Society of Tropical Medicine and Hygiene 110 (8 …, 2016 | 64 | 2016 |
| Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa AD Kerkhoff, R Wood, FG Cobelens, A Gupta-Wright, LG Bekker, ... BMC infectious diseases 14 (1), 3860, 2014 | 57 | 2014 |
| Managing malaria in the intensive care unit M Marks, A Gupta-Wright, JF Doherty, M Singer, D Walker British Journal of Anaesthesia 113 (6), 910-921, 2014 | 53 | 2014 |
| False-negative RT-PCR for COVID-19 and a diagnostic risk score: a retrospective cohort study among patients admitted to hospital A Gupta-Wright, CK Macleod, J Barrett, SA Filson, T Corrah, V Parris, ... BMJ open 11 (2), e047110, 2021 | 46 | 2021 |
| Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study KP Reddy, A Gupta-Wright, KL Fielding, S Costantini, A Zheng, EL Corbett, ... The Lancet Global Health 7 (2), e200-e208, 2019 | 45 | 2019 |
| High HIV and active tuberculosis prevalence and increased mortality risk in adults with symptoms of TB: a systematic review and meta‐analyses M Nliwasa, P MacPherson, A Gupta‐Wright, M Mwapasa, K Horton, ... Journal of the International AIDS Society 21 (7), e25162, 2018 | 32 | 2018 |
| Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and … A Gupta-Wright, EL Corbett, D Wilson, JJ van Oosterhout, K Dheda, ... PLoS medicine 16 (4), e1002776, 2019 | 31 | 2019 |
